Catastrophic antiphospholipid syndrome: task force report summary

R Cervera; I Rodríguez-Pintó; G Espinosa on behalf of the Task Force on Catastrophic Antiphospholipid Syndrome

doi:10.1177/0961203314540764

Catastrophic antiphospholipid syndrome: task force report summary

Lupus. 2014 Oct;23(12):1283-5. doi: 10.1177/0961203314540764.

Authors

R Cervera¹, I Rodríguez-Pintó²; G Espinosa on behalf of the Task Force on Catastrophic Antiphospholipid Syndrome

Collaborators

G Espinosa on behalf of the Task Force on Catastrophic Antiphospholipid Syndrome:
Ricard Cervera, Ignasi Rodríguez-Pintó, Gerard Espinosa, Serena Colafrancesco, Fabrizio Conti, Guido Valesini, Cristina Rosário, Nancy Agmon-Levin, Yehuda Shoenfeld, Claudia Ferrão, Raquel Faria, Carlos Vasconcelos, Flavio Signorelli

Affiliations

¹ Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain rcervera@clinic.cat.
² Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain.

PMID: 25228727
DOI: 10.1177/0961203314540764

Abstract

The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) aimed to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors and treatment of CAPS. This article summarizes the main aspects of its final report.

Keywords: Antiphospholipid syndrome; anticardiolipin antibodies; antiphospholipid antibodies; lupus anticoagulant.

MeSH terms

Advisory Committees
Antiphospholipid Syndrome / classification
Antiphospholipid Syndrome / diagnosis
Antiphospholipid Syndrome / drug therapy
Antiphospholipid Syndrome / etiology*
Humans